Bhavesh Patel


Bhavesh Patel (PhD) is a principal in the Life Sciences Practice at CRA. He has managed numerous strategy consulting projects on topics including pricing and market access, value perception, brand strategy, and launch readiness, engaging with pharmaceutical, biotech, and medical device companies.

Bhavesh has experience across various therapeutic areas including rare diseases, oncology, cardiovascular disease, diabetes, autoimmune disease, and ophthalmology. In addition, he is currently managing CRA’s internal “Rare Diseases” issues leadership platform and has published articles and posters (ISPOR) on the role of PAGs in rare diseases and the funding dynamics for gene/cell therapies, respectively.

Prior to CRA, he was an associate consultant at QuintilesIMS where he also gained experience in market research, data analysis, and project management. Prior to that, he was a postdoctoral research associate for the Medical Research Council. He has also worked as a freelance editor in chemistry and as a research intern at GSK, AstraZeneca, and P&G.

Selected engagements

  • 01
    Evaluating the potential impact of cross-border healthcare for gene therapies
    Issue Our client sought to understand the current state of healthcare across borders (also known as medical tourism) and the opportunities and risks this...
    View engagement
  • 02
    Global pricing and access strategic issues assessment for rare diseases gene therapy portfolio
    Issue Our client is developing gene therapies for different rare disease indications, some with effective treatments available and others with only symptom...
    View engagement